FDA Guidance On Combo HIV Products Will Allow Reviews In Six Weeks

FDA is setting a goal of reviewing fixed-dose combinations of HIV drugs in six weeks as part of the Bush Administration's $15 bil. Emergency Plan for AIDS Relief

More from Archive

More from Pink Sheet